Johns Hopkins University

Shenderov Lab

The Shenderov Lab focuses on the elucidation of the mechanisms of immune resistance and response to immunotherapy in Prostate Cancer. This has led to clinical and basic research investigating the presumptive checkpoint inhibitor B7-H3.

In pursuit of understanding biomarkers and regulatory molecules of immune response, we utilize artificial intelligence, immunogenomics, spatial proteomics, transcriptomics, and clinical trial correlative samples.

Meet The Team

2022 Lab Outing to the Maryland Science Center

We have a lot of fun here...

We keep our team at the center of what we do, striving to foster a welcoming educational and professional environment.

Join us!

Lab Alumni Family

News

Promising Immunotherapy to Treat Localized High-Risk Prostate Cancer

February , 2024

For men with localized high-risk prostate cancer the HEAT trial is active across multiple locations in the United States and investigating if a promising immunotherapy can increase the cure rate of surgery and prevent cancer recurrence.
https://clinicaltrials.gov/study/NCT06014255

News Archive

Dr. Ling Huang Matches to Oncology Fellowship

November 30, 2022

Dr. Huang is heading to Wash. U. in St. Louis! Congratulations!

Publications

Donation

It takes a team, including you, to advance cancer research!

All philanthropy supporting the Shenderov Lab is tax-deductible.

Online Donations:

Please visit our secure online giving page and indicate that

your gift is to support the Eugene Shenderov Lab.

Mail Donations:

Please make your check out to ‘Johns Hopkins University’ and mail to:

Johns Hopkins Kimmel Cancer Center
Development Office
750 East Pratt Street, 17th Floor
Baltimore, MD 21202

If you would like more information about philanthropic giving,

please call the Development Office at410-361-6391.